MedElevator Войти в исследования
← Поиск публикаций

DOI 10.64898/2026.08.13.744719

Медицинская библиотека · bioRxiv : the preprint server for biology · 2026

Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator.

Alfradique-Dunham Isabel, Sanford Jessie, Liu Menghan, Perrin Richard J, Franklin Erin E, Norris Scott, Kotzbauer Paul T, Perlmutter Joel S, Budde John P, Cruchaga Carlos, Ibanez Laura, Minaya Miguel

СтатьяПрепринтПеревод в очереди

Аннотация

Parkinson disease (PD) affects more than 1.1 million individuals in the United States and around 12 million worldwide. Although Genome Wide Association Studies (GWAS) have substantially advanced our understanding of PD genetic architecture, the regulatory mechanisms linking PD risk loci to disease-relevant gene expression remain incompletely characterized, limiting our ability to infer disease mechanisms from genetic associations. Here, we integrated disease-state parietal cortex transcriptomics with the International Parkinson's Disease Genomics Consortium (iPDGC) locus prioritization to refine PD gene nomination and identify biologically plausible candidates missed by GWAS-only approaches. Using bulk RNA-seq from 99 neuropathologically confirmed PD cases and 30 neuropathologically confirmed controls, we prioritized candidate genes across 78 loci and classified them according to concordance between genetic evidence and differential expression in diseased cortices. This integrative approach recovered candidate genes not captured by external GWAS-based prioritization methods and highlighted synaptic, lysosomal, and proteostasis pathways as major components of PD risk biology. Network and transcription factor analyses further suggested coordinated regulation of these genes, with STAT3 emerging as a putative upstream glial regulator. Together, these findings suggest that integrating disease-state transcriptomics with genetic prioritization can refine PD risk-gene nomination and uncover regulatory programs that may be missed by GWAS alone.

Для цитирования: Alfradique-Dunham Isabel, Sanford Jessie, Liu Menghan, Perrin Richard J, Franklin Erin E, Norris Scott, Kotzbauer Paul T, Perlmutter Joel S, Budde John P, Cruchaga Carlos, Ibanez Laura, Minaya Miguel. Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator.. bioRxiv : the preprint server for biology. 2026. DOI: 10.64898/2026.08.13.744719.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.